Laurion Capital Management LP - UROGEN PHARMA LTD ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$5,332,206
+39.6%
380,600
+3.1%
0.03%
+57.1%
Q2 2023$3,820,237
+8.6%
369,105
-3.0%
0.02%
-12.5%
Q1 2023$3,516,744
+4.2%
380,6000.0%0.02%
+50.0%
Q4 2022$3,375,922
+6.6%
380,6000.0%0.02%
-15.8%
Q3 2022$3,167,000
+1.6%
380,6000.0%0.02%
-60.4%
Q2 2022$3,117,000
+76.5%
380,600
+701.7%
0.05%
+433.3%
Q4 2017$1,766,00047,4730.01%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders